NEW DELHI (AP) – India began inoculating health workers on Saturday in what is probably the largest COVID-19 vaccination campaign in the world, joining the ranks of the wealthiest nations where the effort is already underway.
India is home to the largest vaccine manufacturers in the world and has one of the largest immunization programs. But there is no manual for the enormity of the current challenge.
Indian authorities hope to give vaccines to 300 million people, approximately the population of the United States and several times more than the existing program that targets 26 million children. The recipients include 30 million doctors, nurses and other frontline workers, followed by 270 million people over 50 or with illnesses that make them vulnerable to COVID-19.
For workers who pulled India’s battered health care system during the pandemic, vaccines offered confidence that life can begin to return to normal. Many burst with pride.
“I’m excited to be one of the first to get the vaccine,” said Gita Devi, a nurse, as she raised her left sleeve to receive the injection.
“I am happy to receive a vaccine made in India and we do not have to rely on third parties for this,” said Devi, who treated patients during the pandemic at a hospital in Lucknow, capital of Uttar Pradesh, in the heart of India. .
The first dose was administered to a sanitation worker at the All Indian Institute of Medical Sciences in the capital. New Delhi, after Prime Minister Narendra Modi kicked off the campaign with a speech broadcast on national television.
“We are launching the largest vaccination campaign in the world and that shows the world our capacity,” said Modi. He pleaded with citizens to keep their guard high and not believe any “rumors about vaccine safety”.
It was not clear whether Modi, 70, had taken the vaccine himself, like other world leaders, as an example of the safety of the injection. His government said that politicians will not be considered priority groups in the first phase of the launch.
Health officials have not specified what percentage of India’s nearly 1.4 billion people will be targeted by the campaign. But experts say it will almost certainly be the biggest global initiative.
The absolute scale has its obstacles. For example, India plans to rely heavily on a digital platform to track vaccine shipment and delivery. But public health experts point out that the internet remains uneven in large parts of the country, with some remote villages completely disconnected.
About 100 people were due to be vaccinated in each of the 3,006 centers across the country on the first day, the Ministry of Health said.
News cameras captured injections in hundreds of hospitals, reinforcing repressed hopes that vaccination would be the first step in overcoming the pandemic that devastated the lives of so many Indians and affected the country’s economy.
India on January 4 approved emergency use two vaccines, one developed by the University of Oxford and the pharmaceutical company AstraZeneca based in the United Kingdom, and another by the Indian company Bharat Biotech. Cargo planes flew 16.5 million shots to different Indian cities last week.
But doubts about the effectiveness of the vaccine grown locally are creating obstacles to the ambitious plan.
Health experts fear that the regulatory shortcut taken to approve the Bharat Biotech vaccine without waiting for hard data to show its effectiveness in preventing coronavirus disease could amplify the vaccine’s hesitation. At least one state health minister has opposed its use.
In New Delhi, doctors at Ram Manohar Lohia Hospital, one of the largest in the city, demanded that they receive the AstraZeneca vaccine instead of the one developed by Bharat Biotech. A hospital doctors’ union said many of its members were “a little apprehensive about the lack of a complete test” for the internally developed vaccine.
“At the moment, we do not have the option to choose between vaccines,” said Dr. Nirmalaya Mohapatra, vice president of the hospital’s Association of Medical Residents.
The Ministry of Health in India has been angered by the criticism and says the vaccines are safe, but says health professionals will have no choice in deciding which vaccine they will receive.
According to Dr. SP Kalantri, director of a rural hospital in Maharashtra, the hardest hit state in India, such an approach was worrying because he said regulatory approval was hasty and has no scientific backing.
“In a hurry to be populist, the government (is) making decisions that may not be in the common man’s best interest,” said Kalantri.
Against the backdrop of the growing global number of COVID-19 deaths – reaching 2 million on Friday – time is running out to vaccinate as many people as possible. But the campaign was uneven.
In wealthy countries, including the United States, Britain, Israel, Canada and Germany, millions of citizens have already received some measure of protection with at least one dose of vaccines developed with revolutionary speed and quickly authorized for use.
But elsewhere, immunization initiatives are barely off the ground. Many experts are predicting yet another year of losses and difficulties in places like Iran, India, Mexico and Brazil, which together account for about a quarter of COVID-19 deaths worldwide.
India is in second place, behind the United States, with 10.5 million confirmed cases, and in third place in number of deaths, behind the USA and Brazil, with 152,000.
More than 35 million doses of various COVID-19 vaccines have been administered worldwide, according to the University of Oxford.
Although most doses of the COVID-19 vaccine have already been purchased by wealthy countries, COVAX, a UN-supported project to supply vaccines to developing parts of the world, found itself without vaccines, money and logistical aid.
As a result, World Health Organization chief scientist Dr. Soumya Swaminathan warned this week that it is highly unlikely that herd immunity – which would require at least 70% of the globe to be vaccinated – will be achieved this year.
“Even if it happens in some pockets, in some countries, it will not protect people around the world,” she said.
___
Associated Press editor Biswajeet Banerjee in Lucknow, India contributed to this report.